IBM &Amp; Genome Institute of Singapore Collaboration May Lead to Better Understanding of Cell Process Regulation
674893
IBM (NYSE: IBM), in collaboration with the Genome Institute of Singapore (GIS), today revealed results from a joint research study that could potentially alter our views of how cell processes are regulated.
29615
Researchers create three-dimensional structures using DNA-directed assembly.
443190
A conglomerate of Japanese companies hopes to develop biochips.
528813
A centre in Edinburgh is to develop human stem cell lines to help find treatments for diseases like diabetes.
758461
Publications fulfils US' Human Genome commitment
63657
The latest findings may expand the ways of generating customized stem cells for new treatments
193568
Scientists say the results represent a new stage in synthetic biology.
433211
Next-generation sequencing uncovers disease-causing microbes.
464348
A leading human genome scientist says he has taken a major step towards creating life from scratch in the lab.
252451
RNA interference, whose discovery  brought Americans Andrew Fire and Craig Mello the Nobel Prize  in Medicine on Monday, is one of the hottest new areas of  biotechnology and has spawned its own mini-industry.
606125
University of Toronto researchers have identified cells in an adult mouse pancreas capable of generating insulin-producing beta cells.
714769
Heart cells grown from human embryonic stem cells have the potential to be biological pacemakers. Researchers at the Technion Institute in Haifa, Israel have demonstrated that when the embryonic
148078
Graduate students at the University of Toronto have boosted hopes for an effective diabetes treatment after growing insulin-producing tissue from the single cell of a mouse pancreas.
35395
This morning, IBM, in conjunction with Vivendi game developer High Moon Studios and Canadian high-performance developer RapidMind,  launched a coast-to-coast event to interest developers into building a new gaming platform around the Cell.
572566
IBM supercomputer drafted to help do the math on genes connected to cancer, other diseases.
535692
Famed for its computing research, SRI International has grown into a biomedical powerhouse as well. CEO Curt Carlson discusses the company's past, present, and future plans for biotech.
480011
Swiss pharmaceutical company Novartis AG said it has mapped the genome of a large group of type-2 diabetes patients, enabling scientists to better search for the genes causing the disease.